Related Experiment Video
Updated: Oct 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Net Prescription Drug Prices And Spending In Medicare Part D Before And After Generic Entry
Scott Laughery1, Colin Baker2, Rachel Fehr3
1Scott Laughery, Congressional Budget Office, Washington, D.C.
Abstract:
Generic competition lowers retail prescription drug prices, but little is known about its effect on net prices, accounting for manufacturer rebates. Using data on rebates and discounts for Part D, we estimated net prices, prescription volume, and spending before and after generic entry. Total spending fell as generics captured market share, even as total volume rose. Brand-name prices rose in a shrinking segment.
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Nomenclature
Drug Products: Biologics, Biosimilars and Interchangeables
FDA Approved Drugs: Changes to Approved Drugs
Dosage Regimens: Partial Pharmacokinetic Parameters
Drug Dosing: Geriatric Patients